New Medications for the Treatment of Diabetes

Diabetes Technol Ther. 2019 Feb;21(S1):S160-S171. doi: 10.1089/dia.2019.2513.
No abstract available

Publication types

  • Review

MeSH terms

  • Adamantane / analogs & derivatives
  • Adamantane / therapeutic use
  • Benzhydryl Compounds / therapeutic use
  • Blood Glucose / drug effects
  • Canagliflozin / therapeutic use
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptides / therapeutic use
  • Drug Therapy, Combination
  • Glucosides / therapeutic use
  • Glycated Hemoglobin / drug effects
  • Glycosides / therapeutic use
  • Humans
  • Hypoglycemia / chemically induced
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
  • Treatment Outcome

Substances

  • Benzhydryl Compounds
  • Blood Glucose
  • Dipeptides
  • Glucosides
  • Glycated Hemoglobin A
  • Glycosides
  • Hypoglycemic Agents
  • Insulin
  • Sodium-Glucose Transporter 2 Inhibitors
  • hemoglobin A1c protein, human
  • Canagliflozin
  • dapagliflozin
  • (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
  • saxagliptin
  • Adamantane